Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.
Packer, Milton; Zannad, Faiez; Butler, Javed; Filippatos, Gerasimos; Ferreira, Joao Pedro; Pocock, Stuart J; Brueckmann, Martina; Zeller, Cordula; Hauske, Sibylle; Anker, Stefan D; and +1 more...EMPEROR-Preserved Trial Study Group
EMPEROR-Preserved Trial Study Group;
(2021)
Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.
European journal of heart failure, 23 (10).
pp. 1798-1799.
ISSN 1388-9842
DOI: 10.1002/ejhf.2334
RESEARCH LETTER - No abstract available.
-
picture_as_pdf - ejhf.2334.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 3.0
Downloads